Skip to main content

Take Profits in Biogen, Jim Cramer Says

Publish date:
Video Rating:
Video Duration:

Jim Cramer told Action Alerts PLUS senior analyst Jeff Marks that it’s the moment to take profit in Biogen  (BIIB) - Get Free Report after the stock rallied over 38% after FDA approval of its Alzheimer’s drug.

Catch his full take in the video above. 

TheStreet Live Recap: Everything Jim Cramer Is Watching Tuesday

Related Videos